Transdermal formulation is the third drug delivery system after oral drug delivery and injection drug delivery. Its formulation has the advantages of good therapeutic effect and independent medication. To ensure the safety, effectiveness, and stable and controllable quality of drugs, the quality rating of transdermal formulation must be strictly controlled. Key points for quality evaluation of transdermal formulation usually include appearance, identification, release, related substances, residual solvents, content uniformity, content, adhesion, etc. CD Formulation analytical laboratories is a full-service pharmaceutical quality control laboratory offering various pharmaceutical testing options.

About Conventional Characterization for Transdermal Formulation

Ensuring the safety, effectiveness, and quality control of transdermal formulation is the basic principle to be followed in the development and evaluation of transdermal formulations. Among them, the quality control of transdermal formulation is the basis and premise to ensure the safety and effectiveness of drugs. Routine characterization of transdermal formulation is an important step to control the quality and ensure safety of transdermal formulation, in order to allow qualified transdermal formulation to enter the pharmaceutical market and avoid affecting or endangering the life and health of patients. Due to the huge impact of the routine characterization of transdermal formulation, strong professionalism, and high requirements for personnel and equipment configuration, it is more reliable to choose a formal, professional, qualified, and quality management system organization for testing. CD Formulation has decades of experience in transdermal formulation, pharmaceuticals and delivery components. Combined with our analytical expertise, we have the ability to provide analytical support for every stage of development of your transdermal products.

What Can We Offer for Transdermal Formulation Conventional Characterization

• Transdermal Formulation Appearance Analysis
• Transdermal Formulation Rheological Properties Analysis
• Transdermal Formulation Weight Testing
• Transdermal Formulation Thickness Testing
• Transdermal Formulation Folding Endurance Testing
• Transdermal Formulation Moisture Absorption Rate/Water Vapor Absorption Rate Testing
• Transdermal Formulation Moisture Content Percentage Testing
• Transdermal Formulation Surface pH Testing
• Transdermal Formulation Swelling Index Testing
• Transdermal Formulation Tensile Strength Testing
• Transdermal Formulation Drug Content and Excipient Content Assays
• Transdermal Formulation Drug Content Uniformity Testing
• Transdermal Formulation Crystal Structure Analysis
• Transdermal Formulation Peel Adhesion Testing
• Transdermal Formulation Shear Testing
• Transdermal Formulation Release Liner Removal Testing
• Transdermal Formulation Tack Testing
• Transdermal Formulation Cold Flow Evaluation
• Transdermal Formulation Residual Drug Analysis
• In Vitro Penetration Testing of Transdermal Formulation
• In-Vitro Release Testing of Transdermal Formulation

Our Available Methods for Characterizing Transdermal Formulation

Our analytical team specializes in providing regulatory-compliant analytical methods for conventional characterization for the transdermal formulation, including but not limited to:

• The penetration amount of the transdermal formulation was evaluated using the in vitro dermal penetration test (IVPT). Commonly used methods include the vertical Franz diffusion cell method, immersion cell method and flow cell method.

• We utilize the paddle-disc method to measure the release of transdermal formulation. The results can explain the drug release mechanism of the preparation, which is an important detection indicator for early prescription screening and quality control.
• Refer to the "ANDA: Evaluating the Adhesion of Transdermal and Topical Drug Delivery Systems" issued by the US FDA to measure the adhesion.

Our Platform for Transdermal Formulation Conventional Characterization

Our Advantages in Characterizing Transdermal Formulation

• Professional technology and equipment: We are equipped with advanced testing equipment and instruments, as well as experienced professional and technical personnel, who can conduct comprehensive testing of transdermal patches to ensure the quality and safety of the product.
• Standardized operations: We understand and comply with applicable regulations and standards and can ensure the accuracy and reliability of test results.
• Customized services: We can provide customized testing services based on your specific needs and product characteristics. Whether it is the development of new transdermal patches or the improvement of existing products, we can provide professional technical support and solutions.
• Confidentiality and reliability: We focus on the confidentiality of customer information and the reliability of test results. Through strict confidentiality measures and quality control systems, we ensure customer data security and the credibility of test results.

CD Formulation can test conventional characterization for transdermal formulation according to customer requirements. According to your testing requirements, we provide you with appropriate testing programs and professional testing technology. Contact us to learn more about how we can work for you. Our colleagues will reply to you within three working days.